Find a Doctor

MH
Areas of Expertise

Ming-jui L. Hung

Chang Gung University

Bio

Ming-jui Hung is in Keelung, Taiwan. They have been an author on 81 peer reviewed articles in the past 15 years.

Areas of Expertise

Contact

Keelung, TNQ, TW

Latest Research

Latest Advance
Study
  • Condition: Patients with Type 2 Diabetes (T2D) with Non-Alcoholic Fatty Liver Diseases (NAFLDs)
  • Journal: BMJ open diabetes research & care
  • Treatment Used: Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors
  • Number of Patients: 0
  • Published —
This review of the literature examined the effects of sodium glucose co-transporter 2 (SGLT2) inhibitors in patients with type 2 diabetes (T2D) with non-alcoholic fatty liver diseases (NAFLDs).
Latest Advance
Study
  • Condition: Type 2 Diabetes
  • Journal: Cardiovascular diabetology
  • Treatment Used: Sodium Glucose Cotransporter 2 Inhibitors (SGLT2)
  • Number of Patients: 10140
  • Published —
This study compared the glycemic (blood sugar) and pleiotropic effects in patients with type 2 diabetes initiating sodium glucose cotransporter 2 (SGLT2) inhibitors or dipeptidyl peptidase-4 (DPP4) inhibitors.
Latest Advance
Study
  • Condition: First Myocardial Infarction in Patients with Atrial Fibrillation (AF)
  • Journal: PloS one
  • Treatment Used: Drug-Eluting vs. Bare-Metal Stents (BMS)
  • Number of Patients: 1221
  • Published —
This study investigated the use of a bare-metal stent (BMS) or a drug-eluting stent (DES) and associated outcomes in patients with pre-existing atrial fibrillation (heart quivering; AF) and first acute myocardial infarction (heart attack; AMI) undergoing percutaneous coronary intervention.
Latest Advance
Study
  • Condition: Aminotransferase (ALT) levels in people with type 2 diabetes
  • Journal: Diabetes, obesity & metabolism
  • Treatment Used: Sodium-glucose co-transporter-2 inhibitors
  • Number of Patients: 1300000
  • Published —
The study researched the effects of sodium-glucose co-transporter-2 inhibitors on aminotransferase (ALT) levels in people with type 2 diabetes.
Latest Advance
Study
  • Condition: Type 2 Diabetes Mellitus
  • Journal: Journal of diabetes investigation
  • Treatment Used: Vildagliptin
  • Number of Patients: 1250
  • Published —
This study analyzed cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus.

Clinical Trials

This doctor has not participated in any recent clinical trials.

All Publications
View All

Publication
Study
  • Journal: Renal failure
  • Published —
Value of the high-sensitivity troponin T assay for diagnosis of acute myocardial infarction in patients with and without renal insufficiency.
Publication
Study
  • Journal: BMJ open diabetes research & care
  • Published —
SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews.

Contact

Keelung, TNQ, TW

Insurance

Contact them to find out if they accept your insurance plan.